For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more ...

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...

This article was reviewed by Darragh O’Carroll, MD. How Much Does Wegovy® Cost With and Without Insurance? Key takeaways: ...

Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

SEATTLE (Reuters) -U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with their weight-loss injections, analysts and investors say, ...

Novo Nordisk eyes a 2026 comeback as it slashes jobs, cuts U.S. semaglutide prices and focuses on expanding the reach of key ...

MORE than 170 deaths have been linked to fat jabs, it has been revealed. Drug watchdogs have received 173 fatal reports ...